lidoflazine has been researched along with Kidney Failure, Chronic in 1 studies
Lidoflazine: Coronary vasodilator with some antiarrhythmic action.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flameng, WJ | 1 |
| Herijgers, P | 1 |
| Szécsi, J | 1 |
| Sergeant, PT | 1 |
| Daenen, WJ | 1 |
| Scheys, I | 1 |
1 other study available for lidoflazine and Kidney Failure, Chronic
| Article | Year |
|---|---|
Determinants of early and late results of combined valve operations and coronary artery bypass grafting.
Topics: Age Factors; Aged; Aortic Valve; Coronary Artery Bypass; Coronary Disease; Female; Heart Valve Disea | 1996 |